Sam Lee - Profile and Investment Details

Investor Profile

Sam Lee is a Venture Capital, Private Equity Firm based in Cincinnati, Ohio, United States with a diverse investment portfolio that includes companies such as Jersey Watch, Ahalogy, WorkFlex Solutions, Loteda, Standard Bariatrics, Myonexus Therapeutics, Blue Water Vaccines, CincyTech USA, Skinny Mom, Eikonoklastes Therapeutics, ActionStreamer, eMerge Health Solutions, Sqrl, CompleteSet, Viaggi, Stack Construction Technologies, NaviStone, Amify, Petbrosia, ThinkVine, Enable Injections, Airway Therapeutics, Abre.io, StrapInvirsa, Ilesfay Technology Group, Kapture, Eccrine Systems, IncludeHealth, Impulcity, Shopperations Research & Technology, Roadtrippers, Xact Medical, storeFlix, ReadySet Surgical, REPP, SimpleRegistry, Assurex Health, Off Track Planet, LISNR, Clarigent Health, ConnXus, Data Inventions, Semblee, SoMoLend, Soundstr, Cordata Healthcare Innovations, Aerpio Pharmaceuticals, Losant, Astronomer, Frameri, QI Healthcare, Genetesis, StreamSpot, Capstory, Candidly, Batterii, FamilyTech, Peerro, Sirrus, . Over time, Sam Lee has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sam Lee is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Hospitals, E-commerce, Wellness, Women Founded, HR Tech, Life Science, Rehabilitation, Portfolio Management, Education, Artificial Intelligence (AI), Retail, Startups, Information Technology (IT), Cloud Computing, Software, Biotechnology, Medical Devices, Entrepreneurship, Innovation, Employee Benefits, Consumer Internet, Research, Consumer Software, Logistics, Technology Transfer, Health Diagnostics, Digital Health, Data Management, Medical, SaaS, Information Technology, B2B, Therapeutics, Health Tech, Machine Learning, Emergency Medicine, Black / African American Founded, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Sam Lee, as their portfolio suggests a familiarity and interest in this area.

Understanding Sam Lee’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.